Comment in 2019

In this Comment, the author, a cancer researcher and breast cancer survivor, discusses her experience as a patient with cancer and how it influenced her approach to research.

This Comment article argues that the future successes of rare cancer research will require alternative approaches for diagnosing, researching and conducting clinical trials, which will ultimately benefit patients with all types of cancer.

The use of social media for the dissemination of published and unpublished scientific findings has exploded over the past few years. In this Comment article, Soragni and Maitra explain some of the ways in which Twitter can be used by academics to promote their science.

This Comment article argues that genomic, epigenomic and other studies on cancer in diverse populations across low-income and middle-income countries are essential in order to reduce worldwide cancer burden and improve global health.

In an effort to prevent bullying and harassment in the research sector, funding bodies have introduced policies to promote a positive research culture. Here, Sue Russell and Iain Foulkes comment on what this means for researchers.

Cancer brings an increasing health and economic burden worldwide, and the greatest impact is had on the most vulnerable populations. In this Comment, Christopher Wild discusses the need for investment to ensure long-term cancer prevention strategies.